(MedPage Today) -- The rheumatology literature this week explored whether or not patients with vasculitis treated with rituximab also need maintenance therapy, if MRI can predict later arthritis when disease is still subclinical, and how an interleukin (IL)-1 blocker could help in post-traumatic arthritis. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment